Fast Company Magazine Awards Xenco Medical with 2024 Innovation by Design Award for the TrabeculeX Continuum
24 Julio 2024 - 6:39AM
Business Wire
Fast Company Magazine has awarded pioneering life sciences
company Xenco Medical with its prestigious 2024 Innovation by
Design Award for its groundbreaking TrabeculeX Continuum, the first
convergent technology bridging regenerative medicine and digital
health. Unveiled by Xenco Medical at CES 2024, the heralded
platform’s unification of biomaterial implantation and remote
therapeutic monitoring has signified an important advancement in
the extent to which surgeons can maintain a continuous link with
patients from the intraoperative phase throughout the entire course
of recovery. The distinguished award marks the second time in two
consecutive years that Xenco Medical has been recognized by Fast
Company Magazine for its breakthrough innovations. Last year, Xenco
Medical was named one of the World’s Most Innovative Companies by
the esteemed publication.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240724363293/en/
Fast Company Magazine has honored Xenco
Medical for its groundbreaking TrabeculeX Continuum technology with
its 2024 Innovation by Design Award. (Photo: Business Wire)
“We are immensely honored to receive Fast Company’s 2024
Innovation by Design Award for the TrabeculeX Continuum and deeply
grateful for their recognition of our technology’s capacity to
upend the siloed nature of surgical care. Devoted to the
longitudinal recovery of our patients, we look forward to the
continued impact of the TrabeculeX Continuum as a seamless link
from implantation to full mobility,” said Xenco Medical Founder and
CEO Jason Haider.
According to Fast Company Magazine, the Innovation by Design
Award “is one of the most sought-after design awards in the
industry.” “This year’s honorees show how essential creativity is
to the process of innovation,” said Brendan Vaughan,
editor-in-chief of Fast Company. “It’s inspiring to see how some of
the best minds across industries are using design to shape our
world for the better.” Harmonizing the journey from biomaterial
implantation to physical rehabilitation, Xenco Medical’s TrabeculeX
Continuum enables surgeons who’ve used a TrabeculeX Bioactive
Matrix strip in their patient to prescribe and remotely monitor
patient-specific physical rehabilitation plans while engaging in
asynchronous video and text messaging through the TrabeculeX
Recovery App. Intricately designed to conduct three-dimensional
bone-formation, the TrabeculeX Bioactive Matrix’s novel
architecture begins at the sub-micron scale and spans to the entire
lattice itself.
Harnessing the hydroxycarbonate apatite-forming capabilities of
bioglass in every TrabeculeX Bioactive Matrix, the regenerative
biomaterial included in the TrabeculeX Continuum features a complex
surface topography chemically engineered for robust bone
regeneration. Driven by a mission to deliver value-based care
through surgical innovation, Xenco Medical’s breakthrough
technologies have been uniquely centered on addressing the entire
spectrum of a surgical patient’s journey. The Innovation by Design
Awards will be published in the Summer 2024 issue of Fast Company
Magazine, and the honorees will be celebrated in New York City at
the Innovation by Design Awards Reception on the evening of
September 16th.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240724363293/en/
Melissa Russell 858-202-1505 info@xencomedical.com